UK markets open in 1 hour 2 minutes
NIKKEI 225
28,022.19 +239.26 (+0.86%) HANG SENG
20,462.78 +153.65 (+0.76%) CRUDE OIL
74.30 -0.07 (-0.09%) GOLD FUTURES
1,979.00 -1.30 (-0.07%) DOW
32,859.03 +141.43 (+0.43%) Bitcoin GBP
22,598.65 -501.87 (-2.17%)
AstraZeneca PLC (AZN.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 06:22PM BST
Loading interactive chart…
- Zacks
Astrazeneca (AZN) Gains But Lags Market: What You Should Know
In the latest trading session, Astrazeneca (AZN) closed at $68.64, marking a +0.06% move from the previous day.
- Zacks
Ionis (IONS) Posts New Upbeat Data From Amyloidosis Drug Study
Ionis (IONS) reports positive long-term phase III study data, supporting the benefits of eplontersen as a treatment for hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN).
- Business Wire
Eplontersen demonstrated sustained benefit in Phase III trial for hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) through 66 weeks
WILMINGTON, Del., March 27, 2023--Positive high-level results from the NEURO-TTRansform Phase III trial in patients with hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) showed eplontersen met its co-primary endpoints through 66 weeks. The results were consistent with the positive 35-week findings announced in June 2022.1
© 2023 Yahoo. All rights reserved.
